Determination of Molecular Status, the Efficacy and Safety of Fluorodeoxyglucose in PET-CT Imaging | MicrobiomeTrials← Back to trialsNCT04943211
Determination of Molecular Status, the Efficacy and Safety of Fluorodeoxyglucose in PET-CT Imaging
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2021-04-01Est. Completion: 2027-06-30
Enrollment target: 150 participants Locations- Mother and Child Institute, Warsaw, Mazovian, Poland
Other microbiome trials you might be interested in
Recurrent Langerhans Cell HistiocytosisRefractory Langerhans Cell Histiocytosis
This phase II trial tests the safety, side effects, best dose and activity of tovorafenib (DAY101) in treating patients …
Birmingham, United StatesEst. completion Sep 30, 2028
Diffuse Large B-cell-lymphomaDLBCL, Nos Genetic SubtypesFollicular Lymphoma Grade 3BPMBLHGBL With MYC and BCL2 and/or BCL6 RearrangementsHGBL, Nos
This study is to investigate the safety and tolerability of C402-CD19-CAR treatment in subjects with relapsed or refract…
Tianjin, ChinaEst. completion Apr 28, 2029
PirtobrutinibImmunochemotherapyDLBCL - Diffuse Large B Cell LymphomaCNS Involvement of Systemic Lymphoma
This is an open-label, prospective, single-arm, multicenter study designed to evaluate the efficacy and safety of MTX pl…
Shanghai, ChinaEst. completion Sep 1, 2028